Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Regular budget checks are essential for resilience, catching shifts in income or needs and guiding timely adjustments toward stability.
20,660 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Treasury Secretary Scott Bessent dismissed fears of runaway oil prices as Middle East tensions persist, insisting the...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
Eight senior executives have left Canoo in a fresh churn while the EV maker fights to meet long-running production ta...
Palantir has been in the AI spotlight, but its stock has traded volatile. This guide helps you separate hype from fun...
The latest move in Bath Body Works stock has traders buzzing. This article breaks down what sparked the rally, how it...
In a landmark UK ruling, the CMA forces Google to let publishers opt out of AI scraping and to clearly credit content...
Investors are losing money yearly by picking the wrong S&P 500 ETF. Tiny differences in fees and tracking error compo...
The U.S. launches an aircraft strike on Iran after a drone attack on a cargo ship near Hormuz, triggering market vola...
A senior strategist has a bold projection for the S&P 500, arguing the index could reach 8,500 by end-2027 as a geopo...
The Trump administration has paused $259.5 million in Minnesota's Medicaid funding amid fraud concerns, demanding a c...
A regional energy shock is unfolding as the Strait of Hormuz stays shut and exporters curtail shipments. The disrupti...